Skip to content

King Pharmaceuticals KG Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$62.21M+1,724%$24.63M+475%$40.52M+800%$33.67M+575%$3.41M
$8.51M$9.35M$10.37M$11.44M
$339.34M$383.67M$0$0
$964.23M$1.01B+18,229%$1.13B$1.16B
$174.72M$174.4M$174.08M$173.78M
$842.79M$881.67M+97,430%$986.67M$1.01B
42.5M100K+270%100K42.5M
-$6.23M$1.2M+122%$18.95M$24.01M
$121.44M+2,773%$128.28M+2,685%$143.77M+3,106%$150.09M+2,955%$4.23M
$964.23M$1.01B+18,229%$1.13B$1.16B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are King Pharmaceuticals's total assets?
King Pharmaceuticals (KG) holds $964.2M in total assets.
How much debt does King Pharmaceuticals have?
King Pharmaceuticals carries $176.7M in total debt against $121.4M of shareholders' equity, a debt-to-equity ratio of 1.46.
How much cash does King Pharmaceuticals have?
King Pharmaceuticals holds $62.2M in cash and equivalents.
Where does King Pharmaceuticals's balance sheet data come from?
Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.